Antisecretory Factor Glioblastoma Phase 2

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Skåne University Hospital, Lund, Sweden
Contact: Study coordinator (Peter Siesjö, MD) · peter.siesjo@med.lu.se · +46705655778
Contact: Study coordinator (Erik Ehinger, MD) · erik.ehinger@med.lu.se · +46707970783

Study leads

Charlotte Edwardsson
Study Chair
Skane University Hospital
Erik Ehinger, MD
Study Chair
Skane University Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

Glioblastoma · Cerebral Metastases · Meningioma

Abroad (travel likely)RecruitingPHASE2

Lund, Sweden

Anterior Temporal Lobectomy in Temporal Glioblastoma

Newly-diagnosed Glioblastoma · Temporal Lobe

Abroad (travel likely)RecruitingPHASE3

Bonn, Germany

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Anaplastic Astrocytoma, IDH-Wildtype · Anaplastic Oligoastrocytoma · Anaplastic Oligodendroglioma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Glioblastoma (GBM) · Newly Diagnosed Glioblastoma · GBM

Abroad (travel likely)RecruitingPHASE2

Springdale, United States · Los Angeles, United States